Akici Ahmet, Kalaça Sibel, Uğurlu Umit, Toklu Hale Z, Oktay Sule
Department of Pharmacology and Clinical Pharmacology, Marmara University School of Medicine, Haydarpaşa, Istanbul, 34668, Turkey.
Pharm World Sci. 2007 Jun;29(3):116-21. doi: 10.1007/s11096-007-9103-5. Epub 2007 Feb 28.
Since irrational use of antihypertensives has considerable clinical and economical consequences, this study was conducted to evaluate antihypertensive drug utilization in hypertension at seven State Health Centres in Istanbul.
A total of 297 hypertensive patients who accepted to participate in the study were evaluated by a face-to-face questionnaire and a copy of their prescriptions were collected for prescription analysis.
Angiotensin-converting enzyme (ACE) inhibitors (31.7%), calcium channel blockers (28.8%), diuretics (16.2%), beta blockers (7.5%) and others (15.8%) have been prescribed. There were no statistically significant relation between prescribed antihypertensive drug groups and gender, age, and NSAIDs co-prescribing. The most frequent comorbidity in hypertensive patients was diabetes mellitus (10.4%) and calcium channel blockers (35.5%) have been prescribed to them as a first antihypertensive medication. Average cost per prescription was $42.7 +/- 38.1. According to the patients' self-reporting, the majority of them (85%) were prescribed without a physical examination. The physicians failed to write the prescriptions appropriately; only 5% of the scripts contained all information about the drug(s) and use instructions in full format.
The present study indicates that GPs working at primary healthcare centres were rational in terms of antihypertensive drug choice. However, they poorly applied rational pharmacotherapy principles such as (a) writing a "good" prescription which is easily readable by the pharmacist and the patient and that contains full essential information; (b) a medical examination of the patient to assess her/his current clinical condition; and (c) taking care of not prescribing drugs with potential interaction like antihypertensives and NSAIDs together.
由于不合理使用抗高血压药物会产生重大的临床和经济后果,因此开展本研究以评估伊斯坦布尔七家州立健康中心高血压患者的抗高血压药物使用情况。
通过面对面问卷调查对总共297名同意参与研究的高血压患者进行评估,并收集他们的处方复印件用于处方分析。
已开具的抗高血压药物包括血管紧张素转换酶(ACE)抑制剂(31.7%)、钙通道阻滞剂(28.8%)、利尿剂(16.2%)、β受体阻滞剂(7.5%)和其他药物(15.8%)。所开具的抗高血压药物组与性别、年龄以及非甾体抗炎药联合处方之间无统计学显著关系。高血压患者最常见的合并症是糖尿病(10.4%),并且已将钙通道阻滞剂(35.5%)作为首选抗高血压药物开给他们。每张处方的平均费用为42.7美元±38.1美元。根据患者的自我报告,他们中的大多数人(85%)在未进行体格检查的情况下就被开了药。医生未能正确书写处方;只有5%的处方完整包含了关于药物和使用说明的所有信息。
本研究表明,在初级医疗保健中心工作的全科医生在抗高血压药物选择方面是合理的。然而,他们在应用合理的药物治疗原则方面做得很差,例如:(a)开具一份药剂师和患者都能轻松读懂且包含全部基本信息的“好”处方;(b)对患者进行医学检查以评估其当前临床状况;以及(c)注意不同时开具具有潜在相互作用的药物,如抗高血压药和非甾体抗炎药。